PaySign, Inc. Class B Aktie News

Paysign, Inc. (NASDAQ:PAYS ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Affordability Matt Lanford - Chief Payments Officer Conference Call Participants Gary Prestopino - Barrington Research Jon Hickman - Ladenburg Thalmann Operator Good afternoon. My name is Kevin, and I'll be...

First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 First quarter 2024 net income of $309 thousand, or diluted earnings per share of $0.01, versus net loss of $160 thousand, or diluted earnings per share of $(0.00) for first quarter 2023 First quarter 2024 Adjusted EBITDA of $1.7 million, up 135% from $720 thousand for first quarter 2023, while diluted Adjusted EB...

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2024 Earnings Call.

If you're an investor with a high tolerance for risk and a desire for supersized returns, penny stocks should be at the top of your watchlist. While penny stocks are often associated with pump-and-dump schemes and companies on the verge of bankruptcy, there are some real hidden gems trading at bargain valuations that could potentially deliver astronomical returns within a few short years.

PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry. The company has a strong presence with 465 plasma centers and 6.4 million cardholders, as well as sponsorship from large banks and card companies. The recent acquisition of shares by PaySign may lead to increased demand for the stock and l...

PaySign, Inc. (PAYS) Q4 2023 Earnings Call Transcript

For the Full Year Full-year 2023 total revenues of $47.3 million, up 24% from full-year 2022 Full-year 2023 net income of $6.5 million, or diluted earnings per share of $0.12, versus net income of $1.0 million, or diluted earnings per share of $0.02 for full-year 2022 Full-year 2023 Adjusted EBITDA of $6.7 million, up 21% from $5.5 million a year ago, while diluted Adjusted EBITDA per share was...

ATHENS, Greece--(BUSINESS WIRE)-- #IPPC2024--Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17.